Filing Details
- Accession Number:
- 0001209191-11-008239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-09 21:28:24
- Reporting Period:
- 2011-02-07
- Filing Date:
- 2011-02-09
- Accepted Time:
- 2011-02-09 21:28:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103390 | Ardea Biosciences Inc. | RDEA | Pharmaceutical Preparations (2834) | 943200380 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384243 | D Barry Quart | 4939 Directors Place San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-07 | 20,000 | $3.90 | 67,202 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-07 | 20,000 | $26.77 | 47,202 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-02-09 | 15,000 | $3.90 | 62,202 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-07 | 20,000 | $0.00 | 20,000 | $3.90 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-09 | 15,000 | $0.00 | 15,000 | $3.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 140,000 | 2016-12-20 | No | 4 | M | Direct | |
| 125,000 | 2016-12-20 | No | 4 | M | Direct |
Footnotes
- The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 11, 2009.
- The range of sales prices received was $26.56 to $26.95. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- 12.5% of the shares subject to the stock option vested and became exercisable on June 21, 2007, and 12.5% of the shares subject to the stock option vested and became exercisable on December 21, 2007. The remaining shares vest in equal monthly installments over the following 3 years.
Billionaire Hedge Funds
